ÂÜÀòÂÒÂ×

Beñat Mallavia, PhD has worked in the field of biomedical research since 2006. Beñat began their career at the Universidad Autónoma de Madrid, where they completed their PhD in 2006, focusing on Macrophage activation and Fc receptor implication during Atherosclerotic plaque formation. Beñat then moved to UCSF in 2012, where they worked as a Research Specialist and Postdoctoral fellow, studying the application of different antibody treatments to reduce the edema and inflammatory response created by acute and long-term lung injury. In 2020, they joined Marin Biologic Laboratories as Director of Scientific Services and Senior Scientist.

Beñat Mallavia, PhD, has an educational history that spans from 2003 to 2020. Beñat began their studies at the Universidad Complutense de Madrid, where they earned a degree in Biology with a focus in Genetics in 2006. Beñat then pursued a Doctor of Philosophy (Ph.D.) in Cardiovascular Disease and Inflammation in Atherosclerosis at the Universidad Autónoma de Madrid, which they completed in 2012. From 2012 to 2020, they worked as a Postdoctoral Researcher in Immunology at the University of California, San Francisco.